Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells.
This paper describes immunostaining of consecutive sections from 15 cases of fibrocystic change of the breast (including 2 examples of intraductal papilloma), 4 ductal carcinomas-in-situ and 17 invasive carcinomas (4 tubular, 1 papillary, 2 lobular and 10 infiltrating ductal, NOS) with antisera to components of the basement membrane (BM), type IV collagen and laminin, and with the muscle antibodies actin and muscle-specific actin. A simple digestion technique was developed to improve the clarity of BM staining with these antibodies. The BM stains facilitated identification of small invasive foci through breaks in the BM in 2 of the cases which had been reported as pure intraductal carcinoma. Tubular carcinomas were surrounded by abnormal, fragmented, and focally discontinuous BM, a feature which could be used to distinguish this well-differentiated breast carcinoma sub-type from sclerosing adenosis, in which individual acini were invariably surrounded by a continuous BM. BM staining emphasized the fibrovascular core of intraductal papillomas, whereas the BM layer was absent in intraductal, cytologically malignant, papillary projections. Similarly, myoepithelial cells, stained with antisera to muscle actins, were identified in a continuous layer surrounding benign epithelial proliferations. These immunohistochemical staining techniques may thus assist the diagnostic histopathologist in differentiating between benign epithelial proliferations of the breast and well-differentiated invasive breast carcinoma, and in identifying foci of microinvasive carcinoma.
Raymond
W A
WA
Division of Tissue Pathology, Institute of Medical and Veterinary Science, Adelaide, South Australia.
Leong
A S
AS
D000199:Actins / Q000032:analysis / Q000276:immunology*; D000906:Antibodies / Q000032:analysis*; D001485:Basement Membrane / Q000737:chemistry / Q000276:immunology / Q000648:ultrastructure; D001943:Breast Neoplasms / Q000276:immunology / Q000473:pathology* / Q000648:ultrastructure; D002278:Carcinoma in Situ / Q000276:immunology / Q000473:pathology* / Q000648:ultrastructure; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000276:immunology / Q000473:pathology* / Q000648:ultrastructure; D002465:Cell Movement; D003094:Collagen / Q000032:analysis / Q000276:immunology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007797:Laminin / Q000032:analysis / Q000276:immunology*; D009208:Myoepithelioma / Q000276:immunology / Q000473:pathology* / Q000648:ultrastructure; D009361:Neoplasm Invasiveness / Q000175:diagnosis* / Q000276:immunology / Q000648:ultrastructure
D000199:Actins; D000906:Antibodies; D007797:Laminin; D003094:Collagen